California State Teachers Retirement System (CalSTRS)’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.12M Buy
105,132
+25,660
+32% +$767K ﹤0.01% 1291
2025
Q4
$3.04M Sell
79,472
-464
-0.6% -$15.1K ﹤0.01% 1194
2025
Q3
$1.91M Buy
79,936
+7,744
+11% +$146K ﹤0.01% 1424
2025
Q2
$1.07M Hold
72,192
﹤0.01% 1699
2025
Q1
$1.29M Hold
72,192
﹤0.01% 1561
2024
Q4
$1.26M Buy
72,192
+7,041
+11% +$125K ﹤0.01% 1657
2024
Q3
$911K Sell
65,151
-2,215
-3% -$23.1K ﹤0.01% 1840
2024
Q2
$554K Sell
67,366
-7,517
-10% -$50.6K ﹤0.01% 2050
2024
Q1
$577K Sell
74,883
-3,930
-5% -$33.2K ﹤0.01% 2078
2023
Q4
$709K Buy
78,813
+3,389
+4% +$24.7K ﹤0.01% 2027
2023
Q3
$674K Sell
75,424
-4,564
-6% -$64.4K ﹤0.01% 2019
2023
Q2
$1.23M Sell
79,988
-187
-0.2% -$3.4K ﹤0.01% 1790
2023
Q1
$1.8M Buy
80,175
+8,264
+11% +$176K ﹤0.01% 1549
2022
Q4
$1.51M Buy
71,911
+1,407
+2% +$29.8K ﹤0.01% 1645
2022
Q3
$1.74M Sell
70,504
-1,298
-2% -$33.5K ﹤0.01% 1529
2022
Q2
$1.74M Sell
71,802
-528
-0.7% -$13.3K ﹤0.01% 1577
2022
Q1
$1.86M Sell
72,330
-6,086
-8% -$162K ﹤0.01% 1660
2021
Q4
$2.43M Buy
78,416
+2,386
+3% +$67.2K ﹤0.01% 1625
2021
Q3
$1.84M Sell
76,030
-4,395
-5% -$80.7K ﹤0.01% 1771
2021
Q2
$1.17M Sell
80,425
-3,033
-4% -$59.8K ﹤0.01% 2105
2021
Q1
$2.08M Buy
83,458
+9,419
+13% +$260K ﹤0.01% 1716
2020
Q4
$2.02M Hold
74,039
﹤0.01% 1643
2020
Q3
$1.37M Buy
74,039
+11,516
+18% +$224K ﹤0.01% 1711
2020
Q2
$1.28M Sell
62,523
-17
-0% -$271 ﹤0.01% 1730
2020
Q1
$912K Sell
62,540
-705
-1% -$10.6K ﹤0.01% 1725
2019
Q4
$898K Sell
63,245
-713
-1% -$9.11K ﹤0.01% 2034
2019
Q3
$741K Buy
63,958
+206
+0.3% +$3.4K ﹤0.01% 2108
2019
Q2
$1.28M Buy
63,752
+547
+0.9% +$10.8K ﹤0.01% 1821
2019
Q1
$1.43M Sell
63,205
-1,405
-2% -$31K ﹤0.01% 1733
2018
Q4
$1.46M Buy
64,610
+2,714
+4% +$67.5K ﹤0.01% 1675
2018
Q3
$1.78M Buy
61,896
+716
+1% +$20.5K ﹤0.01% 1707
2018
Q2
$1.67M Buy
61,180
+1,224
+2% +$32.6K ﹤0.01% 1727
2018
Q1
$1.34M Sell
59,956
-313
-0.5% -$7.45K ﹤0.01% 1784
2017
Q4
$1.27M Sell
60,269
-840
-1% -$19.2K ﹤0.01% 1862
2017
Q3
$1.52M Sell
61,109
-6,629
-10% -$146K ﹤0.01% 1752
2017
Q2
$1.31M Sell
67,738
-3,600
-5% -$65.3K ﹤0.01% 1871
2017
Q1
$1.32M Sell
71,338
-3,300
-4% -$64.6K ﹤0.01% 1899
2016
Q4
$1.41M Sell
74,638
-2,100
-3% -$42.9K ﹤0.01% 1888
2016
Q3
$1.72M Buy
76,738
+800
+1% +$15.2K ﹤0.01% 1747
2016
Q2
$1.35M Buy
75,938
+1,869
+3% +$30.3K ﹤0.01% 1861
2016
Q1
$1.01M Buy
74,069
+9,288
+14% +$141K ﹤0.01% 2012
2015
Q4
$1.25M Buy
64,781
+1,129
+2% +$22.6K ﹤0.01% 1852
2015
Q3
$1.29M Sell
63,652
-200
-0.3% -$5.92K ﹤0.01% 1829
2015
Q2
$2.12M Buy
63,852
+13,761
+27% +$377K 0.01% 1613
2015
Q1
$1.2M Buy
50,091
+10,800
+27% +$165K ﹤0.01% 1906
2014
Q4
$481K Buy
39,291
+168
+0.4% +$1.74K ﹤0.01% 2506
2014
Q3
$353K Buy
39,123
+323
+0.8% +$3.8K ﹤0.01% 2648
2014
Q2
$456K Buy
38,800
+4,200
+12% +$56.9K ﹤0.01% 2553
2014
Q1
$736K Buy
+34,600
New +$532K ﹤0.01% 2182

Other funds holding TVTX

California State Teachers Retirement System (CalSTRS)'s TVTX Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Travere Therapeutics (TVTX) stake by 32% in Q1 2026, buying an estimated $767K and bringing the position to 105,132 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

California State Teachers Retirement System (CalSTRS) first reported a position in TVTX in Q1 2014 and has held it in 49 quarters since. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 105,132 shares of Travere Therapeutics worth $3.12M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 25,660 Travere Therapeutics shares in Q1 2026, an estimated $767K.
  • Travere Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1291 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Travere Therapeutics in Q1 2014 and has held it in 49 quarters since.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.